Satsuma Pharmaceuticals Inc. buy BiotechBee
Start price
08.09.22
/
50%
€6.30
Target price
31.12.24
€8.00
Performance (%)
-88.33%
End price
14.12.22
€0.74
Summary
This prediction ended on 14.12.22 with a price of €0.74. The BUY prediction by BiotechBee for Satsuma Pharmaceuticals Inc. performed very badly with a performance of -88.33%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Satsuma Pharmaceuticals Inc. | - | - | - |
iShares Core DAX® | 1.518% | 3.456% | 25.970% |
iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% |
iShares Nikkei 225® | 2.808% | 2.743% | 19.597% |
iShares S&P 500 | 0.403% | 2.187% | 28.624% |
According to BiotechBee what are the pros and cons of Satsuma Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Satsuma Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 8,0
In the thread Trading Satsuma Pharmaceuticals Inc.
Buy beendet